Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Coya Therapeutics (COYA) EPS (Basic) (2023 - 2025)

Historic EPS (Basic) for Coya Therapeutics (COYA) over the last 3 years, with Q3 2025 value amounting to -$0.13.

  • Coya Therapeutics' EPS (Basic) rose 5000.0% to -$0.13 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.11, marking a year-over-year decrease of 7076.92%. This contributed to the annual value of -$0.98 for FY2024, which is 2360.75% down from last year.
  • According to the latest figures from Q3 2025, Coya Therapeutics' EPS (Basic) is -$0.13, which was up 5000.0% from -$0.36 recorded in Q2 2025.
  • Coya Therapeutics' EPS (Basic)'s 5-year high stood at $0.15 during Q4 2023, with a 5-year trough of -$0.44 in Q1 2025.
  • Over the past 3 years, Coya Therapeutics' median EPS (Basic) value was -$0.28 (recorded in 2023), while the average stood at -$0.25.
  • Its EPS (Basic) has fluctuated over the past 5 years, first tumbled by 27850.33% in 2024, then skyrocketed by 5000.0% in 2025.
  • Coya Therapeutics' EPS (Basic) (Quarter) stood at $0.15 in 2023, then plummeted by 278.5% to -$0.27 in 2024, then soared by 51.45% to -$0.13 in 2025.
  • Its EPS (Basic) stands at -$0.13 for Q3 2025, versus -$0.36 for Q2 2025 and -$0.44 for Q1 2025.